Learn More
Neuroblastoma is the third common tumor in children. Imaging plays an important role in the diagnosis, staging, treatment planning, response evaluation and in follow-up of a case of Neuroblastoma. The International Neuroblastoma Risk Group task force has recently introduced an imaging-based staging system and laid down guidelines for uniform reporting of(More)
INTRODUCTION Pazopanib is one of the recently introduced first-line therapeutic options in the treatment of metastatic renal cell carcinoma (mRCC). There is no published literature from India on the use of pazopanib in mRCC. MATERIALS AND METHODS We report the efficacy and toxicity analysis of first-line pazopanib therapy administered for patients with(More)
INTRODUCTION The current treatment of metastatic renal cell carcinoma (mRCC) revolves around targeted agents, which have resulted in a median overall survival of 22 to 26 months in registration trials. However, the outcomes in a non-trial, real-world Indian population have not yet been evaluated. MATERIALS AND METHODS The present study was a part of a(More)
AIM Patterns of care for metastatic renal cell carcinomas (mRCC) have seen tremendous reform in the last decade. Here, we present our pattern of care in second-line targeted therapy for mRCC. METHODS Patients with mRCC treated with second-line therapy were included from a prospective database. Demographics, risk stratification, and treatment details were(More)
OBJECTIVE Radiotherapy for synchronous bilateral breast cancer (SBBC) is technically very challenging. This study reports the clinical feasibility, dosimetry and safety of helical tomotherapy (HT) with simultaneous integrated boost (SIB) in patients treated with adjuvant radiotherapy for SBBC. MATERIAL AND METHODS Twenty one women with SBBC treated with(More)
Aim To assess the diagnostic accuracy of CT in local staging of Wilms' Tumor. Method Audit of radiology reports (16 slice CT), surgical notes and histopathological reports in 24 cases of unilateral non-metastatic Wilms' tumour (2012 to 2014). Results 24 patients were eligible. 12 boys, 12 girls, age range of 1-10 years (mean 3.9). 6 patients underwent(More)
  • 1